Korsana Biosciences (KRSA) EBITDA Margin (2019 - 2024)
Korsana Biosciences (KRSA) posted EBITDA Margin of 27.80% for Q4 2024, up 609.24 percentage points from the prior quarter.
Powered by 
Analysis
Korsana Biosciences (KRSA) EBITDA Margin (2019 - 2024) Analysis & Trends
For FY2024, Korsana Biosciences' EBITDA Margin came in at -181.40%.
- Annual EBITDA Margin shows a five-year change of +2532.98 percentage points (FY2019 to FY2024).
- In prior years, Korsana Biosciences' EBITDA Margin was -6220.54% in FY2022 (-4832.33 pp), -1388.20% in FY2021 (+2051.04 pp) and -3439.24% in FY2020 (-724.86 pp).
- The Q4 2024 figure stands as the highest quarterly EBITDA Margin in data going back to Q2 2019.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q1 2022, with a gain of 19369.30 percentage points; the weakest was Q1 2021, with a drop of 19219.97 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Korsana Biosciences | 16.27 Mn | 1.82 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 27.80% |
| Sep 30, 2024 | -581.44% |
| Jun 30, 2022 | -4,384.31% |
| Mar 31, 2022 | -1,819.41% |
| Dec 31, 2021 | -2,681.05% |
| Sep 30, 2021 | -3,070.40% |
| Jun 30, 2021 | -535.87% |
| Mar 31, 2021 | -21,188.71% |
| Dec 31, 2020 | -14,098.50% |
| Sep 30, 2020 | -5,295.00% |
| Jun 30, 2020 | -2,546.33% |
| Mar 31, 2020 | -1,968.74% |
| Dec 31, 2019 | -1,751.05% |
| Sep 30, 2019 | -1,953.93% |
| Jun 30, 2019 | -1,981.20% |
API Access
Korsana Biosciences EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=KRSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "KRSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=KRSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();